Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	extracellular matrix organization	ADAMTS20 FLRT2 ABL2 PLG ADAMTSL3 ADAMTS7 ADAMTSL4 WNT3A	8.29e-08	377	32	8	GO:0030198
GeneOntologyBiologicalProcess	extracellular structure organization	ADAMTS20 FLRT2 ABL2 PLG ADAMTSL3 ADAMTS7 ADAMTSL4 WNT3A	8.46e-08	378	32	8	GO:0043062
GeneOntologyBiologicalProcess	external encapsulating structure organization	ADAMTS20 FLRT2 ABL2 PLG ADAMTSL3 ADAMTS7 ADAMTSL4 WNT3A	8.64e-08	379	32	8	GO:0045229
GeneOntologyCellularComponent	extracellular matrix	ADAMTS20 CFP RELN FLRT2 PLG ADAMTSL3 ADAMTS7 MUC5AC ADAMTSL4 SPON1	2.99e-08	656	32	10	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	ADAMTS20 CFP RELN FLRT2 PLG ADAMTSL3 ADAMTS7 MUC5AC ADAMTSL4 SPON1	3.08e-08	658	32	10	GO:0030312
GeneOntologyCellularComponent	collagen-containing extracellular matrix	ADAMTS20 CFP RELN PLG ADAMTSL4 SPON1	1.34e-04	530	32	6	GO:0062023
GeneOntologyCellularComponent	endoplasmic reticulum lumen	CFP ADAMTS7 ADAMTSL4 SPON1 WNT3A	1.39e-04	332	32	5	GO:0005788
GeneOntologyCellularComponent	cell surface	SLC6A3 PLG LY9 CSF3R ADAMTS7 MRC2 PRLR WNT3A	2.08e-04	1111	32	8	GO:0009986
GeneOntologyCellularComponent	side of membrane	CFP PLG LY9 CSF3R ATP2B1 PRLR	1.88e-03	875	32	6	GO:0098552
GeneOntologyCellularComponent	neuronal cell body membrane	SLC6A3 ATP2B1	1.97e-03	43	32	2	GO:0032809
GeneOntologyCellularComponent	cell body membrane	SLC6A3 ATP2B1	2.35e-03	47	32	2	GO:0044298
GeneOntologyCellularComponent	endocytic vesicle membrane	OCRL CSF3R WNT3A	4.11e-03	212	32	3	GO:0030666
MousePheno	abnormal cell migration	ADAMTS20 RELN FLRT2 PLG CSF3R ADAMTS7 MRC2	2.00e-05	501	25	7	MP:0003091
MousePheno	abnormal conjunctival epithelium morphology	PLG MUC5AC	6.41e-05	7	25	2	MP:0004481
Domain	TSP_1	ADAMTS20 CFP ADAMTSL3 ADAMTS7 ADAMTSL4 SPON1	7.95e-10	63	31	6	PF00090
Domain	TSP1	ADAMTS20 CFP ADAMTSL3 ADAMTS7 ADAMTSL4 SPON1	9.65e-10	65	31	6	SM00209
Domain	TSP1_rpt	ADAMTS20 CFP ADAMTSL3 ADAMTS7 ADAMTSL4 SPON1	9.65e-10	65	31	6	IPR000884
Domain	TSP1	ADAMTS20 CFP ADAMTSL3 ADAMTS7 ADAMTSL4 SPON1	9.65e-10	65	31	6	PS50092
Domain	PLAC	ADAMTSL3 ADAMTS7 ADAMTSL4	3.94e-06	19	31	3	IPR010909
Domain	PLAC	ADAMTSL3 ADAMTS7 ADAMTSL4	3.94e-06	19	31	3	PS50900
Domain	ADAM_spacer1	ADAMTS20 ADAMTS7 ADAMTSL4	7.17e-06	23	31	3	IPR010294
Domain	ADAM_spacer1	ADAMTS20 ADAMTS7 ADAMTSL4	7.17e-06	23	31	3	PF05986
Domain	Reeler	RELN SPON1	7.99e-06	3	31	2	PF02014
Domain	Reeler_dom	RELN SPON1	7.99e-06	3	31	2	IPR002861
Domain	REELIN	RELN SPON1	7.99e-06	3	31	2	PS51019
Domain	Peptidase_M12B_ADAM-TS	ADAMTS20 ADAMTSL3 ADAMTS7	8.18e-06	24	31	3	IPR013273
Domain	PLAC	ADAMTSL3 ADAMTSL4	2.40e-04	14	31	2	PF08686
Domain	Kringle-like	PLG MRC2	1.28e-03	32	31	2	IPR013806
Domain	Peptidase_M12B_N	ADAMTS20 ADAMTS7	1.90e-03	39	31	2	IPR002870
Domain	Pep_M12B_propep	ADAMTS20 ADAMTS7	1.90e-03	39	31	2	PF01562
Domain	DISINTEGRIN_1	ADAMTS20 ADAMTS7	2.00e-03	40	31	2	PS00427
Domain	ADAM_MEPRO	ADAMTS20 ADAMTS7	2.00e-03	40	31	2	PS50215
Domain	DISINTEGRIN_2	ADAMTS20 ADAMTS7	2.00e-03	40	31	2	PS50214
Domain	Reprolysin	ADAMTS20 ADAMTS7	2.00e-03	40	31	2	PF01421
Domain	Peptidase_M12B	ADAMTS20 ADAMTS7	2.00e-03	40	31	2	IPR001590
Domain	Disintegrin_dom	ADAMTS20 ADAMTS7	2.10e-03	41	31	2	IPR001762
Domain	fn3	FLRT2 CSF3R PRLR	2.41e-03	162	31	3	PF00041
Domain	FN3	FLRT2 CSF3R PRLR	3.50e-03	185	31	3	SM00060
Domain	FN3	FLRT2 CSF3R PRLR	4.30e-03	199	31	3	PS50853
Domain	-	FLRT2 LY9 CSF3R ADAMTSL3 PRLR	4.39e-03	663	31	5	2.60.40.10
Domain	FN3_dom	FLRT2 CSF3R PRLR	4.93e-03	209	31	3	IPR003961
Domain	Ig-like_fold	FLRT2 LY9 CSF3R ADAMTSL3 PRLR	5.72e-03	706	31	5	IPR013783
Domain	MetalloPept_cat_dom	ADAMTS20 ADAMTS7	7.96e-03	81	31	2	IPR024079
Domain	-	ADAMTS20 ADAMTS7	7.96e-03	81	31	2	3.40.390.10
Domain	ZINC_PROTEASE	ADAMTS20 ADAMTS7	1.15e-02	98	31	2	PS00142
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	ADAMTS20 CFP ADAMTSL3 ADAMTS7 MUC5AC ADAMTSL4 SPON1	1.99e-11	68	25	7	M27303
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	ADAMTS20 CFP ADAMTSL3 ADAMTS7 ADAMTSL4 SPON1	5.11e-11	39	25	6	M27417
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	ADAMTS20 CFP ADAMTSL3 ADAMTS7 ADAMTSL4 SPON1	5.11e-11	39	25	6	MM15165
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	ADAMTS20 CFP ADAMTSL3 ADAMTS7 MUC5AC ADAMTSL4 SPON1	5.83e-10	109	25	7	MM15164
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	ADAMTS20 CFP ADAMTSL3 ADAMTS7 MUC5AC ADAMTSL4 SPON1	6.63e-10	111	25	7	M27416
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	ADAMTS20 CFP ADAMTSL3 ADAMTS7 MUC5AC ADAMTSL4 SPON1	3.94e-09	143	25	7	M27275
Pathway	REACTOME_DISEASES_OF_METABOLISM	ADAMTS20 CFP ADAMTSL3 ADAMTS7 MUC5AC ADAMTSL4 SPON1	1.86e-07	250	25	7	M27554
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	ADAMTS20 CFP KLHL25 ADAMTSL3 ADAMTS7 USP3 MUC5AC ADAMTSL4 SPON1	4.04e-04	1389	25	9	MM15307
Pathway	KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY	CSF3R PRLR	4.04e-04	17	25	2	M47905
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	ADAMTS20 CFP KLHL25 ADAMTSL3 ADAMTS7 USP3 MUC5AC ADAMTSL4 SPON1	6.31e-04	1475	25	9	M19806
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	ADAMTS20 CFP ADAMTSL3 ADAMTS7 ADAMTSL4 SPON1	1.05e-10	75	34	6	20637190
Pubmed	Arl13b-regulated cilia activities are essential for polarized radial glial scaffold formation.	SLC6A3 RELN ARL13B	6.90e-07	18	34	3	23817546
Pubmed	C-mannosylation and o-fucosylation of thrombospondin type 1 repeats.	CFP SPON1	9.28e-07	2	34	2	12096136
Pubmed	OCRL1 Deficiency Affects the Intracellular Traffic of ApoER2 and Impairs Reelin-Induced Responses.	RELN OCRL	2.78e-06	3	34	2	39062513
Pubmed	A Neuro-hormonal Circuit for Paternal Behavior Controlled by a Hypothalamic Network Oscillation.	SLC6A3 PRLR	2.78e-06	3	34	2	32763155
Pubmed	Repurposing of the multiciliation gene regulatory network in fate specification of Cajal-Retzius neurons.	RELN WNT3A ARL13B	3.40e-06	30	34	3	37321213
Pubmed	Conditional Deletion of the Prolactin Receptor Reveals Functional Subpopulations of Dopamine Neurons in the Arcuate Nucleus of the Hypothalamus.	SLC6A3 PRLR	5.56e-06	4	34	2	27581458
Pubmed	Massive loss of Cajal-Retzius cells does not disrupt neocortical layer order.	RELN WNT3A	5.56e-06	4	34	2	16410414
Pubmed	CCL2/MCP-1 signaling drives extracellular matrix turnover by diverse macrophage subsets.	PLG MRC2	1.39e-05	6	34	2	33543002
Pubmed	DeltaNp73 regulates neuronal survival in vivo.	RELN WNT3A	2.59e-05	8	34	2	19805388
Pubmed	Ascl1 participates in Cajal-Retzius cell development in the neocortex.	RELN WNT3A	2.59e-05	8	34	2	21467208
Pubmed	Cajal-Retzius cells instruct neuronal migration by coincidence signaling between secreted and contact-dependent guidance cues.	RELN WNT3A	3.33e-05	9	34	2	23931996
Pubmed	Radial glia regulate Cajal-Retzius cell positioning in the early embryonic cerebral cortex.	RELN WNT3A	3.33e-05	9	34	2	21185282
Pubmed	Prox1 Regulates the Subtype-Specific Development of Caudal Ganglionic Eminence-Derived GABAergic Cortical Interneurons.	RELN WNT3A	4.15e-05	10	34	2	26377473
Pubmed	Dmrt genes participate in the development of Cajal-Retzius cells derived from the cortical hem in the telencephalon.	RELN WNT3A	5.07e-05	11	34	2	32012381
Pubmed	Hydrocephalus in mouse B3glct mutants is likely caused by defects in multiple B3GLCT substrates in ependymal cells and subcommissural organ.	ADAMTS20 SPON1	5.07e-05	11	34	2	33909046
Pubmed	LIM-homeobox gene Lhx5 is required for normal development of Cajal-Retzius cells.	RELN WNT3A	6.08e-05	12	34	2	20685998
Pubmed	Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics.	ADAMTS20 ADAMTS7	6.08e-05	12	34	2	25770910
Pubmed	Correct setup of the substantia nigra requires Reelin-mediated fast, laterally-directed migration of dopaminergic neurons.	SLC6A3 RELN	7.19e-05	13	34	2	30689541
Pubmed	Early B-cell factors 2 and 3 (EBF2/3) regulate early migration of Cajal-Retzius cells from the cortical hem.	RELN WNT3A	7.19e-05	13	34	2	22421355
Pubmed	Tbr2 expression in Cajal-Retzius cells and intermediate neuronal progenitors is required for morphogenesis of the dentate gyrus.	RELN WNT3A	8.38e-05	14	34	2	23447624
Pubmed	Differential gene expression in migratory streams of cortical interneurons.	RELN FLRT2	8.38e-05	14	34	2	22103416
Pubmed	The role of Foxg1 and dorsal midline signaling in the generation of Cajal-Retzius subtypes.	RELN WNT3A	9.66e-05	15	34	2	17928452
Pubmed	Specific glial populations regulate hippocampal morphogenesis.	RELN WNT3A	1.10e-04	16	34	2	19020026
Pubmed	Shh and Gli3 regulate formation of the telencephalic-diencephalic junction and suppress an isthmus-like signaling source in the forebrain.	RELN WNT3A	1.10e-04	16	34	2	21925158
Pubmed	ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family.	LY9 ADAMTS7	1.25e-04	17	34	2	10464288
Pubmed	PDK1 Deficit Impairs the Development of the Dentate Gyrus in Mice.	RELN WNT3A	1.25e-04	17	34	2	29420689
Pubmed	The mammalian DM domain transcription factor Dmrta2 is required for early embryonic development of the cerebral cortex.	RELN WNT3A	1.41e-04	18	34	2	23056351
Pubmed	Migration Speed of Cajal-Retzius Cells Modulated by Vesicular Trafficking Controls the Size of Higher-Order Cortical Areas.	RELN WNT3A	1.57e-04	19	34	2	26387718
Pubmed	Disrupted dorsal neural tube BMP signaling in the cilia mutant Arl13b hnn stems from abnormal Shh signaling.	WNT3A ARL13B	1.57e-04	19	34	2	21539826
Pubmed	Quantitative lineage analysis identifies a hepato-pancreato-biliary progenitor niche.	FLRT2 ARL13B	1.57e-04	19	34	2	34433966
Pubmed	Neurog1 and Neurog2 control two waves of neuronal differentiation in the piriform cortex.	RELN WNT3A	1.74e-04	20	34	2	24403153
Pubmed	Early dorsomedial tissue interactions regulate gyrification of distal neocortex.	RELN WNT3A	1.93e-04	21	34	2	31729356
Pubmed	Lhx2 regulates the development of the forebrain hem system.	RELN WNT3A	2.12e-04	22	34	2	23307637
Pubmed	Dentate Gyrus Development Requires ERK Activity to Maintain Progenitor Population and MAPK Pathway Feedback Regulation.	RELN WNT3A	2.12e-04	22	34	2	25926459
Pubmed	Functional synergy between cholecystokinin receptors CCKAR and CCKBR in mammalian brain development.	RELN SPON1	2.32e-04	23	34	2	25875176
Pubmed	Secreted metalloproteases ADAMTS9 and ADAMTS20 have a non-canonical role in ciliary vesicle growth during ciliogenesis.	ADAMTS20 ARL13B	2.32e-04	23	34	2	30814516
Pubmed	Lhx2 regulates the timing of β-catenin-dependent cortical neurogenesis.	RELN WNT3A	2.32e-04	23	34	2	26371318
Pubmed	Excessive Wnt/beta-catenin signaling promotes midbrain floor plate neurogenesis, but results in vacillating dopamine progenitors.	SLC6A3 SPON1	2.32e-04	23	34	2	26164566
Pubmed	BAF (mSWI/SNF) complex regulates mediolateral cortical patterning in the developing forebrain.	RELN WNT3A	2.53e-04	24	34	2	36263009
Pubmed	Sfrp1 Modulates Cell-signaling Events Underlying Telencephalic Patterning, Growth and Differentiation.	RELN WNT3A	2.53e-04	24	34	2	30084950
Pubmed	Foxg1 confines Cajal-Retzius neuronogenesis and hippocampal morphogenesis to the dorsomedial pallium.	RELN WNT3A	2.53e-04	24	34	2	15858069
Pubmed	Presenilin 1 in migration and morphogenesis in the central nervous system.	RELN SPON1	2.74e-04	25	34	2	15163631
Pubmed	Zic1 and Zic3 regulate medial forebrain development through expansion of neuronal progenitors.	RELN WNT3A	2.74e-04	25	34	2	17507568
Pubmed	Patterning the dorsal telencephalon: a role for sonic hedgehog?	RELN WNT3A	2.74e-04	25	34	2	17959802
Pubmed	Dentate gyrus morphogenesis is regulated by β-catenin function in hem-derived fimbrial glia.	RELN WNT3A	2.74e-04	25	34	2	36196585
Pubmed	Lamination of the cerebral cortex is disturbed in Gli3 mutant mice.	RELN WNT3A	3.21e-04	27	34	2	18448089
Pubmed	Lateral Thalamic Eminence: A Novel Origin for mGluR1/Lot Cells.	RELN WNT3A	3.45e-04	28	34	2	27178193
Pubmed	A novel role for Dbx1-derived Cajal-Retzius cells in early regionalization of the cerebral cortical neuroepithelium.	RELN WNT3A	3.45e-04	28	34	2	20668538
Pubmed	The Ciliopathy Gene Ftm/Rpgrip1l Controls Mouse Forebrain Patterning via Region-Specific Modulation of Hedgehog/Gli Signaling.	WNT3A ARL13B	3.70e-04	29	34	2	30692221
Pubmed	NFIA controls telencephalic progenitor cell differentiation through repression of the Notch effector Hes1.	RELN WNT3A	4.52e-04	32	34	2	20610746
Pubmed	β-Catenin gain of function in muscles impairs neuromuscular junction formation.	RELN WNT3A	5.10e-04	34	34	2	22627288
Pubmed	Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.	ADAMTS20 ZCWPW1	6.05e-04	37	34	2	24162737
Pubmed	Hes genes and neurogenin regulate non-neural versus neural fate specification in the dorsal telencephalic midline.	RELN WNT3A	6.38e-04	38	34	2	18579678
Pubmed	A SMAD1/5-YAP signalling module drives radial glia self-amplification and growth of the developing cerebral cortex.	RELN KLHL25	6.38e-04	38	34	2	32541003
Pubmed	Cell cycle-related kinase is a crucial regulator for ciliogenesis and Hedgehog signaling in embryonic mouse lung development.	MUC5AC ARL13B	7.07e-04	40	34	2	32317081
Pubmed	Pbx Regulates Patterning of the Cerebral Cortex in Progenitors and Postmitotic Neurons.	RELN WNT3A	7.07e-04	40	34	2	26671461
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	OCRL ABL2 ATP2B1 ARL13B	7.36e-04	421	34	4	36976175
Pubmed	Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators.	RELN WNT3A	7.79e-04	42	34	2	23863479
Pubmed	Wnt/β-catenin signaling regulates sequential fate decisions of murine cortical precursor cells.	RELN WNT3A	9.35e-04	46	34	2	25182747
Cytoband	Ensembl 112 genes in cytogenetic band chr15q25	KLHL25 ADAMTSL3 ADAMTS7	2.30e-04	160	34	3	chr15q25
GeneFamily	ADAMTS like	ADAMTSL3 ADAMTSL4	3.24e-05	7	23	2	947
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS20 ADAMTS7	2.61e-04	19	23	2	50
Coexpression	NABA_MATRISOME	ADAMTS20 RELN PLG ADAMTSL3 ADAMTS7 MUC5AC ADAMTSL4 SPON1 WNT3A	3.91e-06	1008	34	9	MM17056
Coexpression	NABA_MATRISOME	ADAMTS20 RELN PLG ADAMTSL3 ADAMTS7 MUC5AC ADAMTSL4 SPON1 WNT3A	4.51e-06	1026	34	9	M5889
Coexpression	NABA_ECM_REGULATORS	ADAMTS20 PLG ADAMTSL3 ADAMTS7 ADAMTSL4	1.33e-05	238	34	5	M3468
Coexpression	NABA_ECM_REGULATORS	ADAMTS20 PLG ADAMTSL3 ADAMTS7 ADAMTSL4	1.44e-05	242	34	5	MM17062
Coexpression	CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL	FLRT2 ADAMTSL3 MRC2 SPON1	1.58e-05	117	34	4	M39300
Coexpression	NABA_MATRISOME_ASSOCIATED	ADAMTS20 PLG ADAMTSL3 ADAMTS7 MUC5AC ADAMTSL4 WNT3A	3.78e-05	738	34	7	MM17058
Coexpression	NABA_MATRISOME_ASSOCIATED	ADAMTS20 PLG ADAMTSL3 ADAMTS7 MUC5AC ADAMTSL4 WNT3A	4.22e-05	751	34	7	M5885
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST	FLRT2 ADAMTSL3 ADAMTSL4	1.07e-04	71	34	3	M45664
Coexpression	GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN	FLRT2 ATP2B1 MRC2 PRLR	1.18e-04	196	34	4	M4676
Coexpression	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN	SLC6A3 ZCWPW1 PLG PRLR	1.23e-04	198	34	4	M5307
Coexpression	GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN	CSF3R SUCO SPON1 WNT3A	1.25e-04	199	34	4	M3731
Coexpression	GSE3982_EOSINOPHIL_VS_BCELL_UP	KLHL25 ADAMTSL3 MUC5AC ADAMTSL4	1.25e-04	199	34	4	M5406
Coexpression	GSE27786_LIN_NEG_VS_NEUTROPHIL_DN	ATG2A ADAMTSL3 ADAMTSL4 PRLR	1.28e-04	200	34	4	M4795
Coexpression	DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS	ADAMTS20 ADAMTSL3 WNT3A	2.10e-04	89	34	3	M40280
ToppCell	facs-Thymus-nan-3m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS20 PLG CSF3R ADAMTS7	3.87e-06	140	34	4	115bd770a9d5e6f007a9aa0eadf5dba46d500107
ToppCell	facs-Thymus-nan-3m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS20 PLG CSF3R ADAMTS7	3.87e-06	140	34	4	22d126e80bf7d9c0ca6ec686b5cc66fa584a1ab6
ToppCell	facs-Thymus-nan-3m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS20 PLG CSF3R ADAMTS7	3.87e-06	140	34	4	62d1ef8cb78618ed89cac7ec89d7f54de06a90c7
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CFP ATG2A CSF3R ADAMTSL4	1.09e-05	182	34	4	dc32f8f6a3b13918eb8e93c018f5823d86344080
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLRT2 ADAMTSL3 MRC2 SPON1	1.14e-05	184	34	4	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RELN FLRT2 ADAMTSL4 SPON1	1.17e-05	185	34	4	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FLRT2 PLG ADAMTSL3 SPON1	1.19e-05	186	34	4	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	COVID-19-kidney-Stressed_PCT\|kidney / Disease (COVID-19 only), tissue and cell type	KLHL25 PLG FUT6 PRLR	1.22e-05	187	34	4	acd305475f3609800af0d7bc68d83ef41228080b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLRT2 ADAMTSL3 MRC2 SPON1	1.35e-05	192	34	4	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLRT2 ADAMTSL3 MRC2 SPON1	1.35e-05	192	34	4	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	FLRT2 ADAMTSL3 MRC2 SPON1	1.35e-05	192	34	4	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLRT2 ADAMTSL3 MRC2 SPON1	1.38e-05	193	34	4	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	368C-Myeloid-Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CFP ABL2 CSF3R ATP2B1	1.40e-05	194	34	4	f9b9cbd1a418a7cbd151c2425fda6b864db9aa82
ToppCell	368C-Myeloid-Monocyte-CD14+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CFP ABL2 CSF3R ATP2B1	1.43e-05	195	34	4	8da933942e9033e18e25ab47831c269747b1c0b2
ToppCell	368C-Myeloid-Monocyte-CD14+_Monocyte\|368C / Donor, Lineage, Cell class and subclass (all cells)	CFP ABL2 CSF3R ATP2B1	1.46e-05	196	34	4	8095b3c1a87ce5c1c7dcbd951806fa564c795068
ToppCell	368C-Myeloid-Monocyte\|368C / Donor, Lineage, Cell class and subclass (all cells)	CFP ABL2 CSF3R ATP2B1	1.46e-05	196	34	4	3b46a501590aa03e3b7e25943dd43b72ecaf8182
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	FLRT2 ADAMTSL3 ADAMTSL4 MRC2	1.46e-05	196	34	4	eed9fe83ffc1f79493b70778962a671dd9f481e0
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CFP LY9 CSF3R ATP2B1	1.49e-05	197	34	4	4a6eff66a17c5e89bda61d887b736f5c62b93bd7
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLRT2 ADAMTSL3 ADAMTSL4 SPON1	1.49e-05	197	34	4	6b6440f1baad5680cf9e13ca3ab72a2c65523d59
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLRT2 ADAMTSL3 ADAMTSL4 MRC2	1.49e-05	197	34	4	2744cc94883c5d0424677cf5093bbab622933e9b
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLRT2 ADAMTSL3 ADAMTSL4 SPON1	1.55e-05	199	34	4	9846d6a31635fde759d55674631c11ab9270a603
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLRT2 ADAMTSL3 ADAMTSL4 SPON1	1.55e-05	199	34	4	103f657132e830a0e5efeb745afb4b77c208a1fa
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RELN FLRT2 ADAMTSL3 SPON1	1.55e-05	199	34	4	83383d9ae4f501754fd3da0215ce6f0e3c70562c
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FLRT2 ADAMTSL3 ADAMTSL4 MRC2	1.55e-05	199	34	4	8de6d7b2067b22cb9b5f01aa56a3803aebc4406d
ToppCell	wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FLRT2 ADAMTSL3 ADAMTSL4 MRC2	1.55e-05	199	34	4	ab0589c068c24aa989bdca083504fbad0c15221d
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLRT2 ADAMTSL3 MRC2 SPON1	1.58e-05	200	34	4	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLRT2 ADAMTSL3 MRC2 SPON1	1.58e-05	200	34	4	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NRIP2 RELN SPON1	7.42e-05	107	34	3	fc07dd90f280191bd643398eac5c8273651d0925
ToppCell	TCGA-Brain-Recurrent_Tumor\|TCGA-Brain / Sample_Type by Project: Shred V9	SLC6A3 ADAMTS7 WNT3A	1.75e-04	143	34	3	eeb8ce6e051e18b82b74aaf2fc23f0cb87fc96d5
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NRIP2 RELN SPON1	1.75e-04	143	34	3	24fd24846fbef049af669a57d42fcc18928d2b27
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NRIP2 RELN SPON1	1.79e-04	144	34	3	71107275767a0728541a3695715c44874b3e5efc
ToppCell	E18.5-samps-Mesenchymal-Pericyte-pericyte_B\|E18.5-samps / Age Group, Lineage, Cell class and subclass	OCRL ADAMTSL3 ADAMTS7	2.05e-04	151	34	3	8ba15ab24fe2e71df0a2a7511ca451ad2376bd91
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ABL2 ADAMTS7 MRC2	2.18e-04	154	34	3	65dbb60f636562eeba3dafadae9c0c7db2b27476
ToppCell	droplet-Bladder-nan-24m-Hematologic-macrophage\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFP LY9 CSF3R	2.35e-04	158	34	3	4a9d4706876f6e86fc5d63ad6dc7df1b4a5cfd9e
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABL2 MRC2 PRLR	2.39e-04	159	34	3	ded4e3626a62fb6334403b7213b467fb7e8131c3
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ABL2 MRC2 PRLR	2.39e-04	159	34	3	2f6c60ddff2208a68146f9786143d9aefd528840
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NRIP2 RELN SPON1	2.44e-04	160	34	3	0bfdaf979e6f128cba2928ce16bca4d3deff8ac9
ToppCell	Mild_COVID-19-Myeloid-MoAM2\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CFP CSF3R PRLR	2.53e-04	162	34	3	e5fc80ab19d513af6a7e677a5e67bfebca2e963b
ToppCell	droplet-Lung-nan-18m-Lymphocytic-plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NBAS RELN PRLR	2.57e-04	163	34	3	5efecdd8a069a822bc9d35b407092925a865e629
ToppCell	normal_Lymph_Node-Myeloid_cells-Monocytes\|Myeloid_cells / Location, Cell class and cell subclass	CFP CSF3R PRLR	2.57e-04	163	34	3	7d7f18e5c99be125e95bc180823430291b770d05
ToppCell	droplet-Lung-nan-18m-Lymphocytic-Plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NBAS RELN PRLR	2.57e-04	163	34	3	0d94a427f86e62aba12c397c6d7b8cd297f3a0e5
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NBAS RELN PRLR	2.62e-04	164	34	3	b92e7c91910d518627376166c6ea9ed333b3d07e
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NBAS RELN PRLR	2.62e-04	164	34	3	a1e43c6b3e2553f5604100db6e92bf244b70c36d
ToppCell	facs-Marrow-B-cells-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN PRLR SPON1	2.67e-04	165	34	3	361a605d8f833d9ec54b120480dce397da35f9c3
ToppCell	P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ADAMTSL3 MRC2 WNT3A	2.76e-04	167	34	3	5c3d0763f73628c71c71f9883556bb4f1639f3cc
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ABL2 ADAMTSL4 MRC2	2.81e-04	168	34	3	26aa96b2b547d11941cb803995ea3d302ee0518c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLG FUT6 PRLR	2.81e-04	168	34	3	fa0d251693935116adf633d02b7ec4a295100865
ToppCell	facs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OCRL ADAMTSL3 ADAMTSL4	2.86e-04	169	34	3	2d23b4cee060f8adddc430c1c10d4e25205b4af6
ToppCell	facs-Lung-Endomucin-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OCRL ADAMTSL3 ADAMTSL4	2.86e-04	169	34	3	ecaf08e8e0b54d1c97a02bc1f65409fd43d68227
ToppCell	facs-Lung-Endomucin-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OCRL ADAMTSL3 ADAMTSL4	2.86e-04	169	34	3	ad6af6609acf158cb79e45ee7ca9af332be3c40c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLRT2 MRC2 SPON1	2.86e-04	169	34	3	a84490724a206c9bbb145f7ce08613f91d100ac4
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFP CSF3R ATP2B1	2.91e-04	170	34	3	46a81d505de845cc59f80594fce338f7fdb9250f
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFP CSF3R ATP2B1	2.91e-04	170	34	3	1a9a0487c35cf3fd5806d1f0f0e91ef0e0b9cd0a
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFP CSF3R ATP2B1	2.91e-04	170	34	3	830646815410c47e9bca8c9bae75dfc45c9c9b33
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLRT2 MRC2 SPON1	2.96e-04	171	34	3	972fab891135bd755d5526cbc5a963200067b0a6
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ATG2A CSF3R ADAMTSL4	2.96e-04	171	34	3	2b7c5a557c4bc5c573211c4d618bdd6766a24916
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLRT2 MRC2 SPON1	2.96e-04	171	34	3	2a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ATG2A CSF3R ADAMTSL4	2.96e-04	171	34	3	dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs\|normal_Pleural_Fluid / Location, Cell class and cell subclass	CFP NANOGNB MRC2	3.01e-04	172	34	3	200b2e63313b110b8ca59ee5b72c02cc8ed907cd
ToppCell	Endothelial-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	RELN FLRT2 ADAMTSL3	3.01e-04	172	34	3	d4e98ff9c7cbc95457e1d71fa60f151a2f178dae
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFP CSF3R ATP2B1	3.17e-04	175	34	3	cd42020fe57afeaadfbd3ef6d7375e66d71e9669
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A3 MRC2 SPON1	3.17e-04	175	34	3	284fdc7a9d303636a637041846850d19d114861a
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NRIP2 ZCWPW1 MRC2	3.17e-04	175	34	3	12f5fd83c7710fc0c77406f765d9cbd133433b8b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLRT2 IL17REL ADAMTSL3	3.17e-04	175	34	3	795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCell	facs-Marrow-T-cells-24m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A3 PRLR SPON1	3.17e-04	175	34	3	0a01e0104cfa3091bc05b0f1d087c941688169a5
ToppCell	facs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN PRLR SPON1	3.22e-04	176	34	3	5f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45
ToppCell	pdx-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	RELN ABL2 PRLR	3.22e-04	176	34	3	1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZCWPW1 MRC2 SPON1	3.22e-04	176	34	3	cb8fd56a4f935cdda19d7ab43382cdda7c307667
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLG FUT6 PRLR	3.22e-04	176	34	3	1595dbeee336a81e581325d63208ec6262664ee9
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	FLRT2 ADAMTSL3 ADAMTSL4	3.22e-04	176	34	3	08f94b78b27feeb113dbfadbfa7fe34d08b2809b
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTSL3 MRC2 SPON1	3.27e-04	177	34	3	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	COVID-19-Heart-Lymph_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RELN FLRT2 ADAMTSL3	3.27e-04	177	34	3	326fde0734ef0d7272693966d346ca479b9d8147
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLG FUT6 PRLR	3.27e-04	177	34	3	2f81b26be89cc2fd8eafadaf7eae3c6ad6521462
ToppCell	facs-Marrow-B-cells-18m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN PRLR SPON1	3.27e-04	177	34	3	35d42b07d9c31528bf59199e361bb8a3bfbe3b75
ToppCell	COVID-19-kidney-PCT-S1/S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PLG FUT6 PRLR	3.33e-04	178	34	3	23a12d3d971b857d5be8e907334d1f6b49eeeb32
ToppCell	facs-Marrow-T-cells-24m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A3 PRLR SPON1	3.38e-04	179	34	3	3f2934c5f8816a7b7a6aef8d2f83ebf7b2b693bf
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ATG2A CSF3R ATP2B1	3.38e-04	179	34	3	8f7d2730188f67e8ca290c60ba171fc13e0cf69e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PLG FUT6 PRLR	3.38e-04	179	34	3	d1ef7e1cb00336118e387b47f4f8120f53584391
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLG FUT6 PRLR	3.44e-04	180	34	3	1363b3254470f6ff98630d1df83a1bdbacc137e0
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTS20 RELN FLRT2	3.50e-04	181	34	3	e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFP CSF3R ATP2B1	3.50e-04	181	34	3	71e55acd1d8e4307e56534c74a50e7be4d1dda0d
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	ADAMTSL3 MRC2 SPON1	3.50e-04	181	34	3	bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_GGT8P\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADAMTS20 RELN ADAMTSL3	3.50e-04	181	34	3	9842537f9a607d8557c43790008d175edab1f32c
ToppCell	COVID-19-kidney-Stressed_PCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PLG FUT6 PRLR	3.50e-04	181	34	3	6980ea624151da32b7f537f263e40fcb87a02e81
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLG FUT6 PRLR	3.55e-04	182	34	3	e1e58176f533092b6b974ca1ce8b02192a6e193d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLG FUT6 PRLR	3.55e-04	182	34	3	4a9c13932e7163fd37a3dcc4c6ca3bbea5372459
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLG FUT6 PRLR	3.55e-04	182	34	3	57bb5a2da976464ba7c4460106bd9f692008ebd9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLG FUT6 PRLR	3.61e-04	183	34	3	facd6dbe0851b537d70a899ac7485714ab27d071
ToppCell	droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN PRLR SPON1	3.61e-04	183	34	3	ffb1bbbccb34d1a7e99872611f497450039d5019
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLG FUT6 PRLR	3.61e-04	183	34	3	84b64cf728629c3af9a8d2ed15b93adf562c54b8
ToppCell	CF-Myeloid-Neutrophil\|CF / Disease state, Lineage and Cell class	ATG2A CSF3R ATP2B1	3.61e-04	183	34	3	da43827952e6fdee2ce94648c316182f272b321c
ToppCell	normal_Lymph_Node-Myeloid_cells-Monocytes\|normal_Lymph_Node / Location, Cell class and cell subclass	CFP CSF3R PRLR	3.67e-04	184	34	3	3cec28ff076fa53d034428de2bb1a237e0c1568c
ToppCell	COVID-19-kidney-PCT-S1/S2\|kidney / Disease (COVID-19 only), tissue and cell type	PLG FUT6 PRLR	3.67e-04	184	34	3	dc71f22583fc54b89b242cbb602f4bbe86f576ec
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLG FUT6 PRLR	3.67e-04	184	34	3	9434731f651820b05335085582960f08fbf895de
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLRT2 ADAMTSL3 SPON1	3.67e-04	184	34	3	4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FUT6 IL17REL MUC5AC	3.67e-04	184	34	3	01c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell	COPD-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	CFP CSF3R ATP2B1	3.67e-04	184	34	3	ceec41ed5636032aaf7716d1203816ea58bd39bd
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NBAS PRLR SPON1	3.67e-04	184	34	3	42cadfdb5d29a50bd7e901ddd14d42b39e8474f0
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLRT2 ADAMTS7 MRC2	3.67e-04	184	34	3	1c857126c0ea0671f0d60b048efca288d348d653
ToppCell	COVID-19-kidney-Mito-rich_PCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PLG FUT6 PRLR	3.73e-04	185	34	3	1bbc2ba8a20f72f61981b1301cdd6018cdd9150d
Drug	Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A	SLC6A3 CFP FLRT2 LY9 ADAMTS7 MUC5AC	2.12e-07	193	31	6	2283_UP
Drug	Amphotericin B [1397-89-3]; Up 200; 4.4uM; MCF7; HT_HG-U133A	SLC6A3 LY9 MUC5AC MRC2 DBF4B	6.52e-06	197	31	5	3303_UP
Drug	C75; Up 200; 10uM; PC3; HT_HG-U133A	KLHL25 ABL2 PLG FUT6 MRC2	6.52e-06	197	31	5	6399_UP
Drug	Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A	SLC6A3 ADAMTS20 CFP KLHL25 ADAMTS7	6.69e-06	198	31	5	3748_UP
Drug	Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; PC3; HT_HG-U133A	CFP LY9 MUC5AC MRC2 SPON1	6.69e-06	198	31	5	6652_UP
Drug	Sulpiride	SLC6A3 RELN PRLR	2.18e-05	40	31	3	ctd:D013469
Drug	rhamnose	PLG FUT6 MUC5AC MRC2 SPON1	1.11e-04	356	31	5	CID000000840
Drug	Orlistat; Up 200; 10uM; PC3; HT_HG-U133A	ADAMTS20 FLRT2 KLHL25 FUT6	1.29e-04	192	31	4	6388_UP
Drug	Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A	FLRT2 MUC5AC MRC2 DBF4B	1.32e-04	193	31	4	6678_UP
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A	PLG MUC5AC MRC2 SPON1	1.34e-04	194	31	4	5954_UP
Drug	Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A	CFP ABL2 PLG SPON1	1.34e-04	194	31	4	5610_UP
Drug	Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ZCWPW1 KLHL25 ATG2A PRLR	1.37e-04	195	31	4	1532_DN
Drug	rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; PC3; HT_HG-U133A	KLHL25 FUT6 ADAMTS7 MRC2	1.37e-04	195	31	4	5980_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; PC3; HT_HG-U133A	FUT6 ADAMTSL4 DBF4B SPON1	1.37e-04	195	31	4	5813_UP
Drug	Nystatine [1400-61-9]; Up 200; 4.4uM; HL60; HT_HG-U133A	RELN FUT6 ADAMTS7 SPON1	1.37e-04	195	31	4	2500_UP
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; HL60; HT_HG-U133A	FLRT2 FUT6 MRC2 DBF4B	1.37e-04	195	31	4	2336_DN
Drug	Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A	FUT6 ADAMTS7 MRC2 SPON1	1.40e-04	196	31	4	4752_UP
Drug	F0447-0125; Up 200; 10uM; MCF7; HT_HG-U133A	FUT6 ADAMTS7 MRC2 SPON1	1.40e-04	196	31	4	6396_UP
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	ABL2 FUT6 DBF4B PRLR	1.40e-04	196	31	4	987_UP
Drug	Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A	SLC6A3 RELN FLRT2 KLHL25	1.40e-04	196	31	4	6061_UP
Drug	DAPH; Up 200; 10uM; MCF7; HG-U133A	KLHL25 ADAMTS7 MRC2 DBF4B	1.42e-04	197	31	4	624_UP
Drug	Piroxicam [36322-90-4]; Up 200; 12uM; MCF7; HT_HG-U133A	FLRT2 KLHL25 MRC2 SPON1	1.42e-04	197	31	4	2252_UP
Drug	Etoposide [33419-42-0]; Up 200; 6.8uM; PC3; HT_HG-U133A	KLHL25 FUT6 MUC5AC DBF4B	1.42e-04	197	31	4	6681_UP
Drug	0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A	ZCWPW1 KLHL25 DBF4B PRLR	1.42e-04	197	31	4	7052_UP
Drug	Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ADAMTS20 FLRT2 LY9 FUT6	1.42e-04	197	31	4	6083_UP
Drug	aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A	CFP ABL2 MRC2 PRLR	1.42e-04	197	31	4	2664_UP
Drug	Dienestrol [84-17-3]; Up 200; 15uM; PC3; HT_HG-U133A	FLRT2 KLHL25 ABL2 MRC2	1.45e-04	198	31	4	5727_UP
Drug	Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A	FLRT2 KLHL25 LY9 DBF4B	1.45e-04	198	31	4	3624_UP
Drug	Ganciclovir [82410-32-0]; Up 200; 15.6uM; PC3; HT_HG-U133A	LY9 MUC5AC DBF4B SPON1	1.45e-04	198	31	4	6289_UP
Drug	iloprost; Up 200; 1uM; MCF7; HG-U133A	OCRL KLHL25 ADAMTS7 ADAMTSL4	1.45e-04	198	31	4	488_UP
Drug	Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A	FUT6 ADAMTSL3 MUC5AC PRLR	1.45e-04	198	31	4	4422_UP
Drug	Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; PC3; HT_HG-U133A	FLRT2 KLHL25 ABL2 MRC2	1.45e-04	198	31	4	3725_UP
Drug	Budesonide [51333-22-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	RELN LY9 FUT6 ADAMTS7	1.45e-04	198	31	4	5431_UP
Drug	Dicumarol [66-76-2]; Up 200; 11.8uM; PC3; HT_HG-U133A	SLC6A3 KLHL25 ADAMTS7 MRC2	1.45e-04	198	31	4	3766_UP
Drug	Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A	RELN KLHL25 MUC5AC MRC2	1.45e-04	198	31	4	2273_UP
Drug	Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; MCF7; HT_HG-U133A	ADAMTS20 ADAMTS7 PRLR SPON1	1.45e-04	198	31	4	3170_UP
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A	SLC6A3 RELN KLHL25 MRC2	1.45e-04	198	31	4	2259_UP
Drug	Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A	SLC6A3 LY9 ADAMTS7 SPON1	1.48e-04	199	31	4	3186_UP
Drug	Metyrapone [54-36-4]; Up 200; 17.6uM; PC3; HT_HG-U133A	ZCWPW1 KLHL25 LY9 ADAMTSL4	1.48e-04	199	31	4	4606_UP
Drug	CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A	CFP KLHL25 PLG MRC2	1.48e-04	199	31	4	6364_DN
Drug	Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A	CFP ABL2 MUC5AC MRC2	1.48e-04	199	31	4	3546_UP
Drug	Foliosidine [2520-38-9]; Up 200; 13uM; PC3; HT_HG-U133A	ADAMTS20 PLG ADAMTSL4 MRC2	1.48e-04	199	31	4	4295_UP
Drug	estradiol, USP; Up 200; 0.01uM; ssMCF7; HG-U133A	SLC6A3 MRC2 PRLR SPON1	1.48e-04	199	31	4	373_UP
Drug	Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ADAMTS20 CFP PLG FUT6	1.48e-04	199	31	4	4840_UP
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; MCF7; HT_HG-U133A	SLC6A3 FLRT2 ATG2A PRLR	1.48e-04	199	31	4	2287_UP
Drug	Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	FLRT2 ATG2A FUT6 DBF4B	1.48e-04	199	31	4	4946_UP
Drug	Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; HL60; HT_HG-U133A	CFP FLRT2 ABL2 MRC2	1.48e-04	199	31	4	2376_UP
Drug	Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; HL60; HG-U133A	OCRL ABL2 LY9 ADAMTSL4	1.48e-04	199	31	4	1739_UP
Drug	Benzbromarone [3562-84-3]; Up 200; 9.4uM; PC3; HT_HG-U133A	ABL2 FUT6 ADAMTS7 DBF4B	1.48e-04	199	31	4	6669_UP
Drug	Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A	RELN KLHL25 LY9 FUT6	1.51e-04	200	31	4	6095_UP
Drug	Hemicholinium bromide [312-45-8]; Up 200; 7uM; HL60; HG-U133A	FLRT2 OCRL ABL2 ATP2B1	1.51e-04	200	31	4	1601_UP
Drug	Etanidazole [22668-01-5]; Up 200; 18.6uM; PC3; HT_HG-U133A	KLHL25 FUT6 ADAMTSL4 MRC2	1.51e-04	200	31	4	5730_UP
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A	ZCWPW1 FLRT2 KLHL25 SPON1	1.51e-04	200	31	4	3827_DN
Drug	C11998	CFP MUC5AC	1.86e-04	15	31	2	CID005282036
Drug	N-acetyl-L-lysine	CFP PLG	2.41e-04	17	31	2	CID000092907
Drug	fluorodopa F 18	SLC6A3 RELN	4.07e-04	22	31	2	CID000056494
Drug	AC1L1IJY	PLG WNT3A	6.63e-04	28	31	2	CID000004611
Drug	astragaloside A	CFP ATP2B1	9.80e-04	34	31	2	CID000122690
Drug	ciguatoxin	CFP ARL13B	1.04e-03	35	31	2	CID005311333
Drug	3-methoxytyramine	SLC6A3 CFP	1.22e-03	38	31	2	CID000001669
Drug	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide	PLG MUC5AC	1.29e-03	39	31	2	ctd:C078131
Disease	idiopathic pulmonary fibrosis	KLHL25 FUT6 MUC5AC	2.96e-05	57	31	3	EFO_0000768
Disease	Hirschsprung Disease	RELN WNT3A	4.87e-04	31	31	2	C0019569
Disease	mean arterial pressure, unipolar depression	CSF3R ATP2B1	5.20e-04	32	31	2	EFO_0003761, EFO_0006340
Disease	Alzheimer disease	ADAMTS20 RELN ZCWPW1 SPON1	1.60e-03	485	31	4	MONDO_0004975
Disease	cognitive decline measurement	SLC6A3 RELN ZCWPW1 PLG	1.61e-03	486	31	4	EFO_0007710
Disease	cystic fibrosis (is_marker_for)	CSF3R MUC5AC	1.94e-03	62	31	2	DOID:1485 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
QDRWFSTPWSPCSRS	ADAMTSL4	971	Q6UY14
CWKWSPADRPSFAET	ABL2	521	P42684
ASCCGWFKRWREPVR	ARL13B	6	Q3SXY8
TARNNPWFCDCSIKW	FLRT2	306	O43155
TFWVQKRPWLAECTP	ATP2B1	396	P20020
WPWSNCVKERVCRYL	ATG2A	6	Q2TAZ0
SVRCPSWKANSWNEC	ADAMTS20	1471	P59510
QRKCSEQPCPARWWA	ADAMTS7	871	Q9UKP4
CLKFSTSWGSWVRCP	IL17REL	271	Q6ZVW7
RCWPRGFWSEPQSLC	IGLJ1	16	A0A0A0MT76
PACNTSLPAQRWKWV	MRC2	66	Q9UBG0
CTASAWLICWPRPRR	GOLGA2P5	51	Q9HBQ8
RNCHPRCTWTKWFDV	MUC5AC	1741	P98088
RCTWTKWFDVDFPSP	MUC5AC	1746	P98088
VTRDCHPRCTWTKWF	MUC5AC	3516	P98088
RDCHPRCTWTKWFDV	MUC5AC	3951	P98088
RCTWTKWFDVDFPSP	MUC5AC	3956	P98088
LCQPCRSPRWSLWST	CFP	71	P27918
PKPQWRRVAWSYDCT	NBAS	131	A2RRP1
LPAAAKTPCTRFRWW	RELN	1186	P78509
KTPCTRFRWWQPVFS	RELN	1191	P78509
RWTIKAECPQPWRYT	KLHL25	471	Q9H0H3
ARCWVRPFPFVTWGC	DBF4B	506	Q8NFT6
PAKPQWSWRCCLTTL	FUT6	6	P51993
AWLCCSPNRKNPLWP	CSF3R	646	Q99062
FSWCIWKRKGRCSVP	LY9	471	Q9HBG7
PLSLPWRPSCWKESC	NRIP2	6	Q9BQI9
WRPSCWKESCSTGQR	NRIP2	11	Q9BQI9
RMRPWTAWSECTKLC	SPON1	756	Q9HCB6
MRWRSLCCQGWSRTP	NANOGNB	171	Q7Z5D8
LRPWCFTTDPNKRWE	PLG	241	P00747
WDSSGKCRVPAWCDR	OCRL	486	Q01968
QGCRRACCSTWWKSP	CLUHP3	111	Q96NS8
ACCSTWWKSPAQCTR	CLUHP3	116	Q96NS8
WVQCSFPNCGKWRRL	ZCWPW1	256	Q9H0M4
PSLYWRLCWKLVSPC	SLC6A3	516	Q01959
CRSPNKETFTCWWRP	PRLR	36	P16471
WLPSWRVCCKESSSA	SUCO	21	Q9UBS9
SWCCSVCRSNKSPWV	USP3	26	Q9Y6I4
SCEVKTCWWSQPDFR	WNT3A	211	P56704
PTSTRPEWVWSCRCC	nan	96	Q8N1Y9
RDCPARWFTSVWSQC	ADAMTSL3	1481	P82987